Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2018 2
2019 1
2020 3
2021 2
2022 6
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, Papp KA, Bagel J, Bhatia N, Del Rosso JQ, Ferris LK, Green LJ, Hebert AA, Jones T, Kempers SE, Pariser DM, Yamauchi PS, Zirwas M, Albrecht L, Devani AR, Lomaga M, Feng A, Snyder S, Burnett P, Higham RC, Berk DR. Lebwohl MG, et al. Among authors: draelos zd. JAMA. 2022 Sep 20;328(11):1073-1084. doi: 10.1001/jama.2022.15632. JAMA. 2022. PMID: 36125472 Free PMC article.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Zirwas MJ, Draelos ZD, DuBois J, Kircik LH, Moore AY, Stein Gold L, Alonso-Llamazares J, Bukhalo M, Bruce S, Eads K, Green LJ, Guenthner ST, Ferris LK, Forman SB, Kempers SE, Lain E, Lynde CW, Pariser DM, Toth DP, Yamauchi PS, Higham RC, Krupa D, Burnett P, Berk DR. Zirwas MJ, et al. Among authors: draelos zd. JAMA Dermatol. 2023 Jun 1;159(6):613-620. doi: 10.1001/jamadermatol.2023.0846. JAMA Dermatol. 2023. PMID: 37133856 Free PMC article. Clinical Trial.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Blauvelt A, Draelos ZD, Stein Gold L, Alonso-Llamazares J, Bhatia N, DuBois J, Forman SB, Gooderham M, Green L, Guenthner ST, Hebert AA, Lain E, Moore AY, Papp KA, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk DR, Chu DH. Blauvelt A, et al. Among authors: draelos zd. J Am Acad Dermatol. 2024 May;90(5):986-993. doi: 10.1016/j.jaad.2023.12.065. Epub 2024 Jan 20. J Am Acad Dermatol. 2024. PMID: 38253129 Free article. Clinical Trial.
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
Stein Gold L, Lain E, Del Rosso JQ, Gold M, Draelos ZD, Eichenfield LF, Sadick N, Werschler WP, Gooderham MJ, Lupo M. Stein Gold L, et al. Among authors: draelos zd. J Am Acad Dermatol. 2023 Nov;89(5):927-935. doi: 10.1016/j.jaad.2022.08.069. Epub 2023 Sep 1. J Am Acad Dermatol. 2023. PMID: 37656094 Free article.
Co-primary endpoints comprised participants achieving 2-grade reduction from baseline in Evaluator's Global Severity Score (EGSS) and clear/almost clear skin (treatment success) and change from baseline in inflammatory/noninflammatory lesion counts. ...
Co-primary endpoints comprised participants achieving 2-grade reduction from baseline in Evaluator's Global Severity Score (EGSS) and clear/ …
Photoprotection for all: Current gaps and opportunities.
Rigel DS, Lim HW, Draelos ZD, Weber TM, Taylor SC. Rigel DS, et al. Among authors: draelos zd. J Am Acad Dermatol. 2022 Mar;86(3S):S18-S26. doi: 10.1016/j.jaad.2021.12.023. Epub 2021 Dec 20. J Am Acad Dermatol. 2022. PMID: 34942298
The effects of solar radiation on human skin differ based on the skin phototype, presence or absence of photodermatoses, biologic capacity to repair DNA damage, wavelength, intensity of sun exposure, geographic latitude, and other factors, underscoring the need for …
The effects of solar radiation on human skin differ based on the skin phototype, presence or absence of photodermatoses, biolo …
Evaluation of Antioxidants' Ability to Enhance Hyaluronic-acid Based Topical Moisturizers.
Zeichner J, Bussmann T, Weise JM, Maass E, Krüger A, Schade AK, Lain E, Mariwalla K, Kirchner F, Draelos ZD. Zeichner J, et al. Among authors: draelos zd. J Clin Aesthet Dermatol. 2024 Mar;17(3):48-51. J Clin Aesthet Dermatol. 2024. PMID: 38495545 Free PMC article.
BACKGROUND: Hyaluronic acid (HA) is a unique molecule of the extracellular matrix with multiple biological activities. In skin, HA plays an essential role as a humectant, capable of binding up to 1,000 times its mass with water, providing skin with moisture and visc …
BACKGROUND: Hyaluronic acid (HA) is a unique molecule of the extracellular matrix with multiple biological activities. In skin, HA pl …
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne.
Tan J, Draelos ZD, Gooderham MJ, Alexis AF, Graber E, Keri J, Woolery-Lloyd HC, Harper JC, Cook-Bolden FE, Konda A, Tanghetti EA. Tan J, et al. Among authors: draelos zd. J Clin Aesthet Dermatol. 2023 Sep;16(9):42-45. J Clin Aesthet Dermatol. 2023. PMID: 37720201 Free PMC article.
OBJECTIVE: The condition of the skin can vary due to weather fluctuations. Therefore, this post-hoc analysis evaluated efficacy and safety of tazarotene 0.045% lotion in warmer versus colder months. ...Year-round tolerability of tazarotene 0.045% lotion may be due to its l …
OBJECTIVE: The condition of the skin can vary due to weather fluctuations. Therefore, this post-hoc analysis evaluated efficacy and s …
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Kircik LH, Alonso-Llamazares J, Bhatia N, Bukhalo M, Devani AR, Draelos ZD, DuBois J, Gooderham MJ, Kempers SE, Lain E, Lee M, Moore A, Murrell DF, Papp KA, Pariser DM, Sinclair R, Zirwas M, Burnett P, Higham RC, Krupa D, Berk DR. Kircik LH, et al. Among authors: draelos zd. Br J Dermatol. 2023 Sep 15;189(4):392-399. doi: 10.1093/bjd/ljad182. Br J Dermatol. 2023. PMID: 37279795 Clinical Trial.
Patients treated with roflumilast experienced low rates of treatment-emergent adverse events (AEs), with few discontinuations due to an AE. Few patients with skin of colour (11%) and few adolescents (0.7%) were included. CONCLUSIONS: The results support the further develop …
Patients treated with roflumilast experienced low rates of treatment-emergent adverse events (AEs), with few discontinuations due to an AE. …
An Oral Supplement and the Nutrition-Skin Connection.
Draelos ZD. Draelos ZD. J Clin Aesthet Dermatol. 2019 Jul;12(7):13-16. Epub 2019 Jul 1. J Clin Aesthet Dermatol. 2019. PMID: 31531157 Free PMC article.
The relationship between good nutrition and skin health has been difficult to scientifically document. While the minimum daily allowances of nutrients to prevent disease have been established, the optimal nutritional state for skin health is unknown. ...These findin …
The relationship between good nutrition and skin health has been difficult to scientifically document. While the minimum daily allowa …
Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel.
Rigel DS, Taylor SC, Lim HW, Alexis AF, Armstrong AW, Chiesa Fuxench ZC, Draelos ZD, Hamzavi IH. Rigel DS, et al. Among authors: draelos zd. J Am Acad Dermatol. 2022 Mar;86(3S):S1-S8. doi: 10.1016/j.jaad.2021.12.019. Epub 2021 Dec 20. J Am Acad Dermatol. 2022. PMID: 34942296
Most attention has been focused on the effects of UV light, particularly UVB wavelengths (290-320 nm). Accordingly, products to protect skin from sunlight-associated harm (sunscreens) have been developed to minimize UVB exposure. ...VL accounts for approximately half of th …
Most attention has been focused on the effects of UV light, particularly UVB wavelengths (290-320 nm). Accordingly, products to protect s …
24 results